Trans fatty acids
This article was originally published in The Tan Sheet
Executive Summary
Food marketers would be required to disclose the trans fatty acids content of products in the "Nutrition Facts" panel under an FDA proposed rule expected to be published in the Nov. 17 Federal Register. The levels of trans fat also would be considered when attempting to meet the requirements for claims regarding "low saturated fat" and "reduced saturated fat," as well as "lean," "extra lean" and cholesterol claims. Products containing more than 4 g saturated and trans fat combined per serving additionally would be prohibited from making health claims, such as the approved claim for calcium and osteoporosis. The public comment period on the proposal will run for 90 days
You may also be interested in...
Supplement Trans Fat Label Additions Stipulated Under FDA Final Rule
Manufacturers of dietary supplements that contain more than .5 g of trans fat will be required to list the amount of the ingredient, as well as the amounts of saturated fat and cholesterol, on the Supplement Facts panel by Jan. 1, 2006
Supplement Trans Fat Label Additions Stipulated Under FDA Final Rule
Manufacturers of dietary supplements that contain more than .5 g of trans fat will be required to list the amount of the ingredient, as well as the amounts of saturated fat and cholesterol, on the Supplement Facts panel by Jan. 1, 2006
Supplement Trans Fat Label Additions Stipulated Under FDA Final Rule
Manufacturers of dietary supplements that contain more than .5 g of trans fat will be required to list the amount of the ingredient, as well as the amounts of saturated fat and cholesterol, on the Supplement Facts panel by Jan. 1, 2006